Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study

Elective nodal radiotherapy in prostate cancer

(2021) Gert De Meerleer et al.   LANCET ONCOLOGY

SpaceOAR hydrogel spacer injection prior to stereotactic body radiation therapy for men with localized prostate cancer

(2021) Heather A. Payne et al.   MEDICINE

Effectiveness of rectal displacement devices in managing prostate motion: a systematic review

(2020) Mahdieh Afkhami Ardekani et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition

(2020) Ilias Sachpazidis et al.   Radiation Oncology

Radiotherapy for one rectal cancer patient with cirrhosis and moderate to severe thrombocytopenia: a case report

(2018) Xinqi Shi et al.   OncoTargets and Therapy

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

(2017) Charles N. Catton et al.   JOURNAL OF CLINICAL ONCOLOGY

Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis

(2017) Rossella Di Franco et al.   Oncotarget

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

(2016) W. Robert Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

(2016) Luca Incrocci et al.   LANCET ONCOLOGY

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

(2016) David Dearnaley et al.   LANCET ONCOLOGY

Radiation Proctopathy

(2015) Marc Grodsky et al.   Clinics in Colon and Rectal Surgery

Toxicity After External Beam Radiotherapy for Prostate Cancer: An Analysis of Late Morbidity in Men With Diabetes Mellitus

(2013) Kapila Kalakota et al.   UROLOGY

Age and Comorbid Illness Are Associated With Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Prostate Cancer

(2012) Daniel A. Hamstra et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM

(2012) X. Allen Li et al.   MEDICAL PHYSICS

A comparison of dose–volume constraints derived using peak and longitudinal definitions of late rectal toxicity

(2010) Sarah L. Gulliford et al.   RADIOTHERAPY AND ONCOLOGY

Is there a role for endorectal balloons in prostate radiotherapy? A systematic review

(2010) Robert Jan Smeenk et al.   RADIOTHERAPY AND ONCOLOGY

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials

(2009) Gustavo Arruda Viani et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

External Beam Radiotherapy for Prostate Cancer Patients on Anticoagulation Therapy: How Significant is the Bleeding Toxicity?

(2009) Kevin S. Choe et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Modeling of α/β for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer

(2009) Simona Marzi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH